<?xml version="1.0"?>
<Articles JournalTitle="Journal of Pharmaceutical Care">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Pharmaceutical Care</JournalTitle>
      <Issn>2322-4630</Issn>
      <Volume>7</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>03</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Statin-Induced Neuropathic Pain: A Case Report</title>
    <FirstPage>120</FirstPage>
    <LastPage>122</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Vaziri</LastName>
        <affiliation locale="en_US">School of Pharmacy, Kerman University of Medical Science, Kerman, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Habib</FirstName>
        <LastName>Mofakham</LastName>
        <affiliation locale="en_US">Neuromuscular research center, Department of physical medicine and rehabiliation, University of California, Davis</affiliation>
      </Author>
      <Author>
        <FirstName>Fanak</FirstName>
        <LastName>Fahimi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The most reported form of statin induced pain is myalgia, conversely peripheral neuropathy is a rare side effect. We report a patient who received rosuvastatin for hypercholesterolemia and experienced episodes of pain in both hands during the night. Rosuvastatin was stopped and atorvastatin was replaced. Re-introduction with another statin resulted in a more severe form of the similar adverse effect after 4 months. This is a rare adverse effect of a extensively prescribed class of drug. Physicians should be aware of the possibility of peripheral neuropathy symptoms in patients on statin therapy.</abstract>
    <web_url>https://jpc.tums.ac.ir/index.php/jpc/article/view/294</web_url>
    <pdf_url>https://jpc.tums.ac.ir/index.php/jpc/article/download/294/217</pdf_url>
  </Article>
</Articles>
